AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 58 filers reported holding AGILE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $178,447,000 | +758.4% | 21,294,485 | -50.0% | 3.57% | +2133.8% |
Q4 2021 | $20,788,000 | +35.9% | 42,588,970 | +167.5% | 0.16% | -27.9% |
Q3 2021 | $15,301,000 | -63.9% | 15,919,925 | -50.0% | 0.22% | -19.3% |
Q2 2021 | $42,348,000 | +27.9% | 31,839,850 | +100.0% | 0.28% | -34.4% |
Q1 2021 | $33,113,000 | -27.5% | 15,919,925 | 0.0% | 0.42% | -14.5% |
Q4 2020 | $45,690,000 | -5.6% | 15,919,925 | 0.0% | 0.49% | -30.7% |
Q3 2020 | $48,397,000 | +9.4% | 15,919,925 | 0.0% | 0.71% | -1.4% |
Q2 2020 | $44,257,000 | +49.5% | 15,919,925 | +0.0% | 0.72% | -7.0% |
Q1 2020 | $29,611,000 | -0.6% | 15,919,325 | +33.6% | 0.77% | +30.2% |
Q4 2019 | $29,799,000 | +134.4% | 11,919,925 | +11.1% | 0.59% | +73.1% |
Q3 2019 | $12,711,000 | +21.7% | 10,726,750 | +27.3% | 0.34% | +42.5% |
Q2 2019 | $10,443,000 | -17.9% | 8,426,750 | 0.0% | 0.24% | -33.1% |
Q1 2019 | $12,724,000 | +629.6% | 8,426,750 | +138.7% | 0.36% | +680.4% |
Q2 2018 | $1,744,000 | -80.8% | 3,530,000 | 0.0% | 0.05% | -81.9% |
Q1 2018 | $9,072,000 | -0.2% | 3,530,000 | +4.4% | 0.25% | -15.6% |
Q4 2017 | $9,092,000 | – | 3,380,000 | +8047519.0% | 0.30% | – |
Q1 2017 | $0 | -100.0% | 42 | -100.0% | 0.00% | -100.0% |
Q4 2016 | $3,770,000 | -47.1% | 661,446 | -35.2% | 0.27% | -41.7% |
Q3 2016 | $7,120,000 | +81.9% | 1,020,011 | +98.3% | 0.46% | +69.7% |
Q2 2016 | $3,914,000 | +260.1% | 514,288 | +193.9% | 0.27% | +185.3% |
Q1 2016 | $1,087,000 | – | 175,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|